Asporin, a candidate protein for treatment of disc degenerative disease

Chinese Medical Journal

Volumn 126, Issue 2, 2013, Pages 369-372

  Tian, Wei ^a   Zheng, Shan ^a   Jiang, Xiao Zhou ^a   Wu, Cheng Ai ^b   Wang, Na ^b   Zhao, Dan Hui ^b  

^a Jishuitan Orthopaedic College of Tsinghua University   (China)

^b Beijing Institute of Traumatology and Orthopaedics   (China)

Author keywords

Asporin; Candidate protein; Disc degenerative disease

Indexed keywords

AGGRECAN; AMINO ACID; ASPORIN; COLLAGEN TYPE 2; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; DEGENERATIVE DISEASE; DISC DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTERVERTEBRAL DISC DEGENERATION; REPETITIVE SEQUENCES, AMINO ACID;

EID: 84872709125     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20110246     Document Type: Article

References (34)

1. Ferguson SJ, Steffen T. Biomechanics of the aging spine. Eur Spine J 2003; 12: S97-S103.
2. Podichetty VK. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol 2007; 53: 4-18.
3. Hohaus C, Ganey TM, Minkus Y, Meisel HJ. Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J 2008; 17: 492-503.
4. Nishida K, Suzuki T, Kakutani K, Yurube T, Maeno K, Kurosaka M, et al. Gene therapy approach for disc degeneration and associated spinal disorders. Eur Spine J 2008; 17: 459-466.
5. Levin DA, Hale JJ, Bendo JA. Adjacent segment degeneration following spinal fusion for degenerative disc disease. Bull NYU Hosp Jt Dis 2007; 65: 29-36.
6. Nabhan A, Steudel WI, Pape D, Ishak B. Segmental kinematics and adjacent level degeneration following disc replacement versus fusion: RCT with three years of follow-up. J Long Term Eff Med Implants 2007; 17: 229-236.
7. Nabhan A, Ahlhelm F, Pitzen T, Steudel WI, Jung J, Shariat K, et al. Disc replacement using Pro-Disc C versus fusion: a prospective randomised and controlled radiographic and clinical study. Eur Spine J 2007; 16: 423-430.
8. Denaro V, Papalia R, Denaro L, Di Martino A, Maffulli N. Cervical spinal disc replacement. J Bone Joint Surg Br 2009; 91: 713-719.
9. Yoon ST. The potential of gene therapy for the treatment of disc degeneration. Orthop Clin North Am 2004; 35: 95-100.
10. Vadala G, Sowa GA, Kang JD. Gene therapy for disc degeneration. Expert Opin Biol Ther 2007; 7: 185-196.
11. Paesold G, Nerlich AG, Boos N. Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J 2007; 16: 447-468.
12. Battie MC, Videman T, Kaprio J, Gibbons LE, Gill K, Manninen H, et al. The Twin Spine Study: contributions to a changing view of disc degeneration. Spine J 2009; 9: 47-59.
13. Videman T, Battie MC, Parent E, Gibbons LE, Vainio P, Kaprio J. Progression and determinants of quantitative magnetic resonance imaging measures of lumbar disc degeneration: a five-year follow-up of adult male monozygotic twins. Spine 2008; 33: 1484-1490.
14. Battie MC, Videman T, Levalahti E, Gill K, Kaprio J. Genetic and environmental effects on disc degeneration by phenotype and spinal level: a multivariate twin study. Spine 2008; 33: 2801-2808.
15. Sambrook PN, MacGregor AJ, Spector TD. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum 1999; 42: 366-372.
16. Gruber HE, Ingram JA, Hoelscher GL, Zinchenko N, Hanley EN Jr, Sun Y. Asporin, a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc. Arthritis Res Ther 2009; 11: R47.
17. Gruber HE, Sage EH, Norton HJ, Funk S, Ingram J, Hanley EN Jr. Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse. J Histochem Cytochem 2005; 53: 1131-1138.
18. Solovieva S, Lohiniva J, Leino-Arjas P, Raininko R, Luoma K, Ala-Kokko L, et al. Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. Eur Spine J 2006; 15: 613-619.
19. Urano T, Narusawa K, Shiraki M, Usui T, Sasaki N, Hosoi T, et al. Association of a single nucleotide polymorphism in the insulin-like growth factor-1 receptor gene with spinal disc degeneration in postmenopausal Japanese women. Spine 2008; 33: 1256-1261.
20. Henry SP, Takanosu M, Boyd TC, Mayne PM, Eberspaecher H, Zhou W, et al. Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. J Biol Chem 2001; 276: 12212-12221.
21. Lorenzo P, Aspberg A, Onnerfjord P, Bayliss MT, Neame PJ, Heinegard D. Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J Biol Chem 2001; 276: 12201-12211.
22. Ikegawa S. Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr Med Chem 2008; 15: 724-728.
23. Kou I, Nakajima M, Ikegawa S. Expression and regulation of the osteoarthritis-associated protein asporin. J Biol Chem 2007; 282: 32193-32199.
24. Yamada S, Tomoeda M, Ozawa Y, Yoneda S, Terashima Y, Ikezawa K, et al. PLAP-1/asporin, a novel negative regulator of periodontal ligament mineralization. J Biol Chem 2007; 282: 23070-23080.
25. Kizawa H, Kou I, Iida A, Sudo A, Miyamoto Y, Fukuda A, et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005; 37: 138-144.
26. Iida A, Kizawa H, Nakamura Y, Ikegawa S. High-resolution SNP map of ASPN, a susceptibility gene for osteoarthritis. J Hum Genet 2006; 51: 151-154.
27. Urban JP, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther 2003; 5: 120-130.
28. Mustafa Z, Dowling B, Chapman K, Sinsheimer JS, Carr A, Loughlin J. Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population. Arthritis Rheum 2005; 52: 3502-3506.
29. Jiang Q, Shi D, Yi L, Ikegawa S, Wang Y, Nakamura T, et al. Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J Hum Genet 2006; 51: 1068-1072.
30. Atif U, Philip A, Aponte J, Woldu EM, Brady S, Kraus VB, et al. Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 2008; 16: 1174-1177.
31. Nakamura T, Shi D, Tzetis M, Rodriguez-Lopez J, Miyamoto Y, Tsezou A, et al. Meta-analysis of association between the ASPN D-repeat and osteoarthritis. Hum Mol Genet 2007; 16: 1676-1681.
32. Song YQ, Cheung KM, Ho DW, Poon SC, Chiba K, Kawaguchi Y, et al. Association of the asporin D14 allele with lumbar-disc degeneration in Asians. Am J Hum Genet 2008; 82: 744-747.
33. Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem 2007; 282: 32185-32192.
34. Kou I, Nakajima M, Ikegawa S. Binding characteristics of the osteoarthritis-associated protein asporin. J Bone Miner Metab 2010; 28: 395-402.